Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Unlocking the Next 3 Trillion-Dollar Stock Opportunities
07:45am, Tuesday, 30'th Jul 2024
In 2008, Apple (NASDAQ: AAPL ) became the first U.S.-traded company to reach a $1 trillion market valuation. Today, there are seven trillion-dollar companies, mostly in tech.
1 Weight Loss Pharma Stock to Buy, and 1 to Consider
07:07am, Tuesday, 30'th Jul 2024
Big pharmas and biotechs alike are rushing to develop weight loss therapies. Eli Lilly's blockbuster products are likely to remain profitable and relevant.
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
06:50am, Tuesday, 30'th Jul 2024
There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
06:50pm, Monday, 29'th Jul 2024
In the most recent trading session, Eli Lilly (LLY) closed at $807.79, indicating a +0.39% shift from the previous trading day.
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
04:00pm, Monday, 29'th Jul 2024
NEW YORK--(BUSINESS WIRE)---- $MORF #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. (“Morphic”) (NASDAQ: MORF) and
Eli Lilly's $123 billion market value drop: A strategic buying opportunity?
03:13pm, Monday, 29'th Jul 2024
Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics I
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lilly
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
09:20am, Monday, 29'th Jul 2024
The market for weight loss therapies is going to get larger and larger. Novo Nordisk and Eli Lilly both have powerful new candidates in the pipeline.
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
04:00pm, Sunday, 28'th Jul 2024
NEW YORK, July 28, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. (“Morphic”) (NASDAQ: MORF) and Eli
7 Smart Stocks to Buy BEFORE They Report Q2 Earnings
01:00pm, Sunday, 28'th Jul 2024
We're into the second week of the earnings season, and some of the top banking companies and other big guns have reported results. The start of the season looks good, and every investor hopes to see t
NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lilly
Is Eli Lilly Stock a Buy?
04:55am, Sunday, 28'th Jul 2024
Mounjaro has become a leading GLP-1 product and could drive years of growth at Eli Lilly. The company has a great product portfolio and pipeline.
These 2 Growth Stocks Are Set to Soar This Summer and Beyond
08:15am, Saturday, 27'th Jul 2024
Healthcare and travel are two sectors where spending is soaring these days. Eli Lilly's portfolio of products and emerging pipeline have extensive ongoing blockbuster potential.
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
07:15am, Saturday, 27'th Jul 2024
Eli Lilly and Regeneron are among the world's leading drugmakers. Both stocks have performed exceptionally well in recent years.
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lilly
